Vycor Medical (VYCO) EV to CFO (2013 - 2026)

Vycor Medical (VYCO) has reported EV to CFO for 14 consecutive years, with 449.55 the latest figure, recorded in Q2 2026.

• On a quarterly basis, EV to CFO fell 594.58% year-over-year to 449.55 in Q2 2026; TTM through Jun 2026 was 35.47, a 106.77% increase from a year earlier, with the FY2025 full-year figure at 290.83, down 883.78% from the prior year.
• EV to CFO was 449.55 for Q2 2026 at Vycor Medical, down from 28.46 in the prior quarter.
• Over five years, EV to CFO peaked at 1532.98 in Q1 2024 and troughed at 449.55 in Q2 2026.
• A 5-year average of 91.83 and a median of 4.63 in 2026 frame the typical range for EV to CFO.
• Across the five-year window, EV to CFO soared 1210.7% in 2024 and slumped 594.58% in 2026, its largest moves.
• Over 5 years, EV to CFO stood at 86.66 in 2022, then jumped by 634.87% to 463.51 in 2023, then slumped by 112.57% to 58.27 in 2024, then jumped by 271.39% to 99.86 in 2025, then slumped by 550.18% to 449.55 in 2026.
• The last three EV to CFO figures came in at 449.55 (Q2 2026), 28.46 (Q1 2026), and 99.86 (Q4 2025), per Business Quant data.